Plexus Corp (NASDAQ: PLXS), a provider of electronic manufacturing services and supply chain solutions, disclosed that President and Chief Executive Officer Todd P. Kelsey sold 1,500 shares of common stock on July 15, 2026, pursuant to a Rule 10b5-1 trading plan adopted in November 2025. The transactions were executed at prices ranging from $260.51 to $261.68 per share. Following the sales, Kelsey maintained beneficial ownership of 67,388 shares of the company's common stock.
Key Points
- NASDAQ: PLXS
- President and CEO Todd P. Kelsey sold 1,500 shares of Plexus common stock on July 15, 2026
- The transaction was executed under a Rule 10b5-1 plan established on November 20, 2025, allowing pre-planned trades independent of material nonpublic information considerations
- Kelsey retained 67,388 shares of beneficial ownership following the sales, retaining a significant stake in the manufacturing services company
Executive Equity Reduction During Q3 2026
On July 15, 2026, Todd P. Kelsey, who serves as both President and Chief Executive Officer of Plexus Corp, executed the sale of 1,500 shares of the company's common stock. The transaction involved two separate sales: 500 shares sold at $260.51 per share and 1,000 shares sold at a weighted average price of $261.0701 per share, reflecting multiple executions within a single trading session. The combined proceeds from these transactions represent a routine portfolio management activity by the company's top executive during the third quarter of 2026.
The sales occurred within the context of a prearranged trading arrangement, which permits executives to establish systematic equity reduction plans without the regulatory uncertainty that typically surrounds insider trades. This type of structured trading program is designed to provide transparency to investors and regulatory authorities regarding the timing and pricing of equity transactions by company officers and directors.
Rule 10b5-1 Plan Adoption and Executive Compliance Framework
The reported stock transactions were executed pursuant to a Rule 10b5-1 trading plan that Kelsey adopted on November 20, 2025. This regulatory framework allows corporate insiders to establish predetermined schedules for buying or selling company securities while maintaining compliance with securities laws regarding insider trading. By adopting such a plan well in advance of actual trading activity, executives can demonstrate that their transactions are not based on access to material nonpublic information available to them through their positions within the company.
The adoption of a Rule 10b5-1 plan represents a common practice among senior executives seeking to diversify personal investment portfolios while maintaining appropriate governance standards. The plan's establishment in November 2025 indicates that these July 2026 transactions were contemplated and approved through established corporate governance protocols several months prior to execution. This advance planning protects both the executive and the company from allegations that trading decisions were influenced by confidential business information.
Plexus Corp Business Operations and Market Position
Plexus Corp operates as a provider of electronic manufacturing services (EMS) and integrated supply chain solutions to original equipment manufacturers across multiple industries including medical devices, aerospace and defense, industrial, automotive, and networking and communications sectors. The company's business model centers on delivering manufacturing, logistics, and supply chain management services to customers who outsource production requirements. As a NASDAQ-listed manufacturer, Plexus competes in a capital-intensive industry with significant operational complexity and customer concentration dynamics.
The company's executive leadership, including President and CEO Todd P. Kelsey, is responsible for overseeing strategic direction, operational execution, and financial performance across the global organization. Kelsey's equity stake in the company, which totaled 67,388 shares following the July 2026 transaction, reflects his ongoing financial alignment with shareholder interests despite the periodic reduction of his personal holdings through structured trading arrangements.
Post-Transaction Beneficial Ownership Position
Following completion of the July 15, 2026 transactions, Todd P. Kelsey maintained direct beneficial ownership of 67,388 shares of Plexus Corp common stock. This ownership position was recorded immediately after the disposition of 1,500 shares, representing the culmination of that day's trading activity. The maintenance of a substantial share position by the company's President and CEO demonstrates continued material financial interest in the company's operational and financial outcomes.
The beneficial ownership calculation reflects all securities directly owned by Kelsey without attribution of any indirect holdings or derivative positions. The disclosure of post-transaction ownership levels provides investors with current information regarding the equity stakes held by senior management, enabling assessment of management alignment with shareholder value creation objectives. The retention of approximately 67,000 shares by the CEO indicates a meaningful personal financial commitment to the organization's long-term performance.
Weighted Average Pricing and Trade Execution Details
The second tranche of Kelsey's stock sales involved 1,000 shares executed at multiple prices within a single trading session, with the reported weighted average price of $261.0701 per share reflecting the aggregate cost across several individual transactions. The filing indicates that the actual execution occurred at prices ranging from $261.00 to $261.68 per share, demonstrating normal intraday market price volatility. This reporting methodology provides transparency while acknowledging the practical reality of large institutional or insider trades frequently being executed across multiple price points.
The weighted average pricing approach allows for simplified disclosure of complex multi-tranche transactions while the company undertakes to provide detailed transaction-by-transaction information to SEC staff, the company itself, and security holders upon request. This dual-level disclosure framework balances the need for clear public reporting with the administrative complexity of providing granular pricing data for every individual execution within a larger transaction block.
Director and Officer Status of the Reporting Executive
Todd P. Kelsey holds dual responsibility as both a Director and an Officer of Plexus Corp, with his Officer designation specifically identifying him as President and Chief Executive Officer. This combined status places Kelsey within the most senior governance and operational leadership of the organization. The Form 4 disclosure identifies both relationship categories, indicating that Kelsey's equity transactions are subject to regulatory reporting requirements applicable to insiders holding these elevated positions within the company's structure.
The concurrent Director and Officer roles reflect the typical corporate governance structure of public companies where the Chief Executive Officer also serves on the company's Board of Directors. This dual position provides Kelsey with comprehensive visibility into both strategic decisions made by the Board and operational execution managed through the executive team. His equity transactions, therefore, occur within the context of full access to all material information regarding the company's business performance and future prospects.
Investor Considerations Regarding Insider Trading Activity
Investors monitoring insider transaction activity by Plexus Corp leadership should note that the implementation of a Rule 10b5-1 trading plan does not necessarily signal concerns regarding the company's outlook or performance. Such plans serve primarily as portfolio diversification mechanisms for executives holding concentrated positions in company equity. The adoption of a formalized trading schedule allows executives to systematically reduce their holdings over time while maintaining full compliance with insider trading regulations and corporate governance standards.
The July 2026 transactions represent execution of a plan adopted eight months earlier in November 2025, suggesting that any trading activity reflects previously established strategic decisions rather than responses to current market conditions or recent company performance developments. Investors should assess insider trading disclosures within their proper context as routine portfolio management activities governed by established regulatory frameworks rather than as indicators of management sentiment regarding near-term company prospects.
Regulatory Reporting Standards and Beneficial Ownership Disclosure
The Form 4 disclosure filed on July 16, 2026, two business days following the July 15 transaction date, complies with Securities Exchange Act requirements governing timely reporting of insider transactions by company directors and officers. The document establishes the current beneficial ownership position of the reporting executive and creates a public record of equity transactions for purposes of regulatory oversight and investor information. The filing identifies the transaction code as "S" (representing sale), the specific security class involved (Common Stock with par value of $0.01), and the quantities and prices associated with each transaction component.
The beneficial ownership calculation methodology distinguishes between direct ownership held in the executive's own name and any indirect beneficial ownership through family members, partnerships, trusts, or other ownership vehicles. In Kelsey's case, all reported holdings are designated as direct ownership, eliminating the need for disclosure of indirect beneficial ownership arrangements or family relationships affecting equity holdings. The clear designation of ownership form provides investors with precision regarding the nature and structure of executive equity positions.
Compliance Framework and Executive Management Authority
The Form 4 filing was executed under authority granted to Kate A. Gitter, identified as Attorney-in-Fact for Todd P. Kelsey. The use of an attorney-in-fact arrangement allows executives to delegate the administrative and legal responsibilities for securities transaction reporting to qualified personnel within legal or compliance departments. This represents standard practice among publicly-traded companies seeking to ensure accuracy and timeliness of insider trading disclosures while accommodating the operational demands on senior executives.
The filing date of July 16, 2026 reflects compliance with SEC regulations requiring insiders to report transactions within two business days of execution. The document's certification by the attorney-in-fact underscores the legal significance of Form 4 filings and the potential federal criminal penalties associated with intentional misstatement or omission of material facts. These regulatory safeguards establish the credibility and reliability of insider transaction disclosures for investors relying on such information for investment decision-making.



Please wait processing your request...